Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
2
April
2018
Publication date Collection: 2018
Volume: 13
Issue: 4
Electronic Location Identifier: e0195281
Affiliations
[1
]
International Health Management Associates, Schaumburg, Illinois, United States of
America
[2
]
AstraZeneca Pharmaceuticals, Waltham, Massachusetts, United States of America
Cornell University, UNITED STATES
Author notes
Competing Interests: All work was performed at IHMA and sponsored by AstraZeneca Pharmaceuticals, LP, which
also included compensation fees for manuscript preparation. AstraZeneca’s rights to
ceftazidime-avibactam were acquired by Pfizer in December 2016. G.S. was an employee
of and shareholder in AstraZeneca Pharmaceuticals at the time of the study, and is
currently an employee of Pfizer. M.W., M.E., D.S. and K.K. are employees of IHMA which
received funding from AstraZeneca for the conduct of the study and development of
this manuscript. None of the IHMA authors have any personal financial interest in
the study sponsor (AstraZeneca Pharmaceuticals, LP) to disclose. This does not alter
our adherence to all PLOS ONE policies on sharing data and materials.
[¤]
Current address: Pfizer, Inc., Groton, Connecticut, United States of America
Author information
Article
Publisher ID:
PONE-D-17-43607
DOI: 10.1371/journal.pone.0195281
PMC ID: 5880376
PubMed ID: 29608599
SO-VID: 232e92ad-87ab-4bed-89e7-1faa5058ea1d
Copyright © © 2018 Wise et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
All work was performed at IHMA and sponsored by AstraZeneca Pharmaceuticals, LP, which
also included compensation fees for manuscript preparation. AstraZeneca’s rights to
ceftazidime-avibactam were acquired by Pfizer in December 2016.
Subject:
Research Article
Subject:
Research and Analysis Methods
Subject:
Experimental Organism Systems
Subject:
Model Organisms
Subject:
Escherichia Coli
Subject:
Research and Analysis Methods
Subject:
Model Organisms
Subject:
Escherichia Coli
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Medical Microbiology
Subject:
Microbial Pathogens
Subject:
Bacterial Pathogens
Subject:
Escherichia Coli
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Pathogens
Subject:
Microbial Pathogens
Subject:
Bacterial Pathogens
Subject:
Escherichia Coli
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Bacteria
Subject:
Enterobacteriaceae
Subject:
Escherichia
Subject:
Escherichia Coli
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Bacteria
Subject:
Gut Bacteria
Subject:
Escherichia
Subject:
Escherichia Coli
Subject:
Research and Analysis Methods
Subject:
Experimental Organism Systems
Subject:
Prokaryotic Models
Subject:
Escherichia Coli
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Microbial Control
Subject:
Antimicrobial Resistance
Subject:
Medicine and Health Sciences
Subject:
Pharmacology
Subject:
Antimicrobial Resistance
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Bacteria
Subject:
Enterobacteriaceae
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Bacteria
Subject:
Klebsiella
Subject:
Klebsiella Pneumoniae
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Medical Microbiology
Subject:
Microbial Pathogens
Subject:
Bacterial Pathogens
Subject:
Klebsiella
Subject:
Klebsiella Pneumoniae
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Pathogens
Subject:
Microbial Pathogens
Subject:
Bacterial Pathogens
Subject:
Klebsiella
Subject:
Klebsiella Pneumoniae
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Bacteria
Subject:
Enterobacter
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Medical Microbiology
Subject:
Microbial Pathogens
Subject:
Bacterial Pathogens
Subject:
Enterobacter
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Pathogens
Subject:
Microbial Pathogens
Subject:
Bacterial Pathogens
Subject:
Enterobacter
Subject:
Biology and Life Sciences
Subject:
Anatomy
Subject:
Body Fluids
Subject:
Blood
Subject:
Medicine and Health Sciences
Subject:
Anatomy
Subject:
Body Fluids
Subject:
Blood
Subject:
Biology and Life Sciences
Subject:
Physiology
Subject:
Body Fluids
Subject:
Blood
Subject:
Medicine and Health Sciences
Subject:
Physiology
Subject:
Body Fluids
Subject:
Blood
Subject:
Biology and Life Sciences
Subject:
Genetics
Subject:
Gene Identification and Analysis
Subject:
Genetic Screens
Subject:
Research and Analysis Methods
Subject:
Database and Informatics Methods
Subject:
Biological Databases
Subject:
Sequence Databases
Subject:
Research and Analysis Methods
Subject:
Database and Informatics Methods
Subject:
Bioinformatics
Subject:
Sequence Analysis
Subject:
Sequence Databases
